Washington University School of Medicine

Digital Commons@Becker
2020-Current year OA Pubs

Open Access Publications

6-1-2021

Elevated mRNA expression and defective processing of cathepsin
D in HeLa cells lacking the mannose 6-phosphate pathway
Lin Liu
Washington University School of Medicine in St. Louis

Balraj Doray
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/oa_4
Part of the Medicine and Health Sciences Commons

Recommended Citation
Liu, Lin and Doray, Balraj, "Elevated mRNA expression and defective processing of cathepsin D in HeLa
cells lacking the mannose 6-phosphate pathway." FEBS Open Bio. 11, 6. 1695 - 1703. (2021).
https://digitalcommons.wustl.edu/oa_4/437

This Open Access Publication is brought to you for free and open access by the Open Access Publications at
Digital Commons@Becker. It has been accepted for inclusion in 2020-Current year OA Pubs by an authorized
administrator of Digital Commons@Becker. For more information, please contact vanam@wustl.edu.

Lin Liu* and Balraj Doray
Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA

Keywords
cathepsin B; cathepsin D; cathepsin L;
GlcNAc-1-phosphotransferase; lysosomes;
mannose 6-phosphate pathway
Correspondence
B. Doray, Department of Internal Medicine,
Division of Hematology, Campus Box 8125,
Washington University School of Medicine,
660 South Euclid Avenue, St. Louis, MO
63110, USA
Fax: (314) 362 8826
Tel: (314) 362 8803
E-mail: bd@wustl.edu
*Present Address
M6P Therapeutics, 20 S. Sarah Street,
St. Louis, MO, 63108, USA
(Received 29 December 2020, revised 18
March 2021, accepted 16 April 2021)
doi:10.1002/2211-5463.13169

Disruption of the mannose 6-phosphate (M-6-P) pathway in HeLa cells by
inactivation of the GNPTAB gene, which encodes the a/b subunits of
GlcNAc-1-phosphotransferase, results in missorting of newly synthesized
lysosomal acid hydrolases to the cell culture media instead of transport to
the endolysosomal system. We previously demonstrated that the majority
of the lysosomal aspartyl protease, cathepsin D, is secreted in these
GNPTAB/ HeLa cells. However, the intracellular content of cathepsin D
in these cells was still greater than that of WT HeLa cells which retained
most of the protease, indicating a marked elevation of cathepsin D expression in response to abrogation of the M-6-P pathway. Here, we demonstrate that HeLa cells lacking GlcNAc-1-phosphotransferase show a
fivefold increase in cathepsin D mRNA expression over control cells,
accounting for the increase in cathepsin D at the protein level. Further, we
show that this increase at the mRNA level occurs independent of the transcription factors TFEB and TFE3. The intracellular cathepsin D can still
be trafficked to lysosomes in the absence of the M-6-P pathway, but fails
to undergo proteolytic processing into the fully mature heavy and light
chains. Uptake experiments performed by feeding GNPTAB/ HeLa cells
with various phosphorylated cathepsins reveal that only cathepsin B is capable of partially restoring cleavage, providing evidence for a role for
cathepsin B in the proteolytic processing of cathepsin D.

Edited by Pierre Cosson

The proper delivery of the 60 or so newly synthesized
acid hydrolases to the lysosome of a cell is essential
for the degradation of intracellular and endocytosed
materials within this organelle [1]. Key among these
enzymes are the lysosomal proteases known as
cathepsins, all of which are initially made as inactive
pre-proenzymes in the endoplasmic reticulum (ER)
[2]. Following removal of the signal peptide within
the lumen of the ER, the proenzyme, also called a
zymogen, acquires N-linked glycans as it transits
from the ER through the compartments of the Golgi.

Transport of the pro-cathepsins from the trans-Golgi
network (TGN) to the endolysosomal system via the
mannose 6-phosphate (M-6-P)-dependent pathway
requires tagging of these acid hydrolases with the M6-P moiety on their high-mannose glycans in the cisGolgi, a process mediated by the enzyme UDPGlcNAc:lysosomal enzyme N-acetylglucosamine-1phosphotransferase
(GlcNAc-1-phosphotransferase)
[3]. Upon reaching the lysosome, the pro-cathepsins
undergo specific proteolytic cleavage events for catalytic activation.

Abbreviations
GlcNAc-1-phosphotransferase, UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase; M-6-P, mannose 6-phosphate;
TFEB, Transcription Factor EB; TFE3, Transcription Factor E3.
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Elevated mRNA expression and defective processing
of cathepsin D in HeLa cells lacking the mannose
6-phosphate pathway

Cathepsin D is the most ubiquitously expressed lysosomal aspartyl protease with especially high levels in
the human brain [4]. In addition to the metabolic
breakdown of proteins in the lysosome, cathepsin D is
involved in a diverse array of physiologic processes,
including activation of growth factors, hormones and
enzyme precursors, processing of antigens, and regulation of apoptosis [5]. Mutations of the human gene
encoding cathepsin D, CTSD, that severely impair
enzyme activity gives rise to the lysosomal storage disorder neuronal ceroid lipofuscinosis [6]. Cathepsin D
has also been implicated in a number of other pathological conditions including atherosclerosis, cancer,
cardiovascular disease, and neurodegenerative disorders such as Alzheimer’s, Huntington’s, and Parkinson’s diseases [7].
During the course of studying a HeLa cell line
(GNPTAB/ cells) with inactivation of the M-6-P
pathway, we found that although 80% of the newly
synthesized cathepsin D was secreted by these cells,
the remaining 20% of intracellular cathepsin D
exceeded the level observed with the parental HeLa
cells, wherein upward of 90% of the newly synthesized
cathepsin D was retained [8]. This indicated that
cathepsin D protein expression was markedly elevated
in the GNPTAB/ HeLa cells. Moreover, we and
others noted that these cells accumulate only procathepsin D while failing to convert this single-chain
molecule to the two-chain form [8–10]. Here, we
demonstrate that in the absence of the M-6-P pathway,
cathepsin D gene expression in HeLa cells is elevated
fivefold at the mRNA level but this upregulation
occurs independent of either Transcription Factor EB
(TFEB) or Transcription Factor E3 (TFE3), two transcription factors that function as master regulators of
lysosomal homeostasis [11]. We further determine that
it is the absence of cathepsin B that is responsible for
the failure to detect cathepsin D processing in the
GNPTAB/ HeLa cells.
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100 000 UL1 penicillin, 100 mgL1 streptomycin (Life
Technologies), and 2 mM L-glutamine (Life Technologies).

Antibodies
The following antibodies were used in this study: anti-V5
mouse monoclonal antibody (Thermo Fisher Scientific,
Waltham, MA, USA Cat #R960-25), anti-cathepsin D rabbit polyclonal antibody (generated in our lab), anti-Lamp1
mouse monoclonal antibody (H4A3) (Development Studies
Hybridoma Bank, Iowa City, IA, USA), anti-cathepsin B
3E4 mouse monoclonal antibody (a generous gift from
Bonnie Sloane, Martin Luther University, Halle-Wittenberg, Germany), and anti-cathepsin L goat polyclonal antibody (R&D Systems, Inc. Minneapolis, MN, USA Cat
#AF1515).

DNA constructs
The construction of the full-length GNPTAB cDNA [12]
and the truncated S1-S3 cDNA [13], both in the vector
pcDNA6/V5-His, has been described. The cDNAs for
expression of cathepsins B, C, L, and Z in Expi 293 cells
were all purchased from OriGene (Rockville, MD, USA).

Immunofluorescence microscopy
GNPTAB/, GNPTG/, and parental Hela cells were
fixed with 4% formaldehyde (Sigma-Aldrich, St. Louis,
MO, USA) and permeabilized in 0.1% (vol/vol) Triton X100 in PBS. Cells were blocked for 1 h with 2% IgG-free
BSA (Jackson Immuno-Research, West Grove, PA, USA)
and probed with the indicated combinations of antibodies
as described in the figure legend. The images were acquired
with an LSM880 confocal microscope (Carl Zeiss, Inc.,
Peabody, MA, USA) in the Molecular Microbiology Imaging Facility at Washington University School of Medicine
in St. Louis. Images were analyzed by IMAGEJ software
(NIH, Bathesda, MD, USA).

Reverse transcriptase quantitative PCR (RT-qPCR)

Materials and methods
Cell lines
Generation of the GNPTAB/ and GNPTG/ HeLa cell
line has been described in detail previously [12]. Mutant
and parental HeLa cell lines were maintained in Dulbecco’s
Modified Eagle Medium (Life Technologies, Carlsbad, CA,
USA), while Expi293 cells (Life Technologies) were grown
in suspension in Expi293 expression medium (Life Technologies). All media contained 0.11 gL1 sodium pyruvate
and 4.5 gL1 glucose, supplemented with 10% (vol/vol)
FBS (Atlanta Biologicals, Flowery Branch, GA, USA),
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Total RNA was extracted with TRIzol reagent (Thermo
Fisher Scientific) from parental HeLa, GNPTAB/, and
GNPTG/ cells according to the manufacturer’s instructions. RNA concentration was determined by measuring
the OD260 value. Two hundred nanogram of RNA from
each cell line was first reverse-transcribed using Omniscript
RT Kit (Qiagen, Hilden, Germany) in a total volume of
20 µL to produce first-strand cDNA. qPCR was then carried out using a StepOnePlus thermocycler (Applied Biosystems, Foster City, CA, USA). The reaction was performed
in triplicate using SYBR Green Master Mix (Bio-Rad, Hercules, CA, USA) following the manufacturer’s protocol,
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and gene expression was calculated by either the 2-DCT or
the 2–ΔΔCT method, using the human ACTB gene as the reference gene.
The following primers were used in this study for RTqPCR:
0
0
CTSB fwd 5 GAATGGCACACCCTACTGG3
50
30
rev TGATCGGTGCGTGGAATTC
0
0
CTSC fwd 5 AACTGCACCTATCTTGACCTG3
50
30
rev CTGTATCCAGCTTCTGAAGGTAC
0
0
CTSD fwd 5 GGACTACACGCTCAAGGTG3
50
30
rev GTTGTCACGGTCAAACACAG
0
0
CTSF fwd 5 CCCTTGGCTCATTGACCATG3
50
30
rev GGACCCACGATGCAAGTAG
0
0
CTSH fwd 5 AACTGTGCGTGAACTCCTTAG3
50
30
rev TGTGGGCGTTTATCTTCCTC
0
0
CTSK fwd 5 GAAGACCCACAGGAAGCAATA3
50
30
rev TGTATGGACACCAAGAGAAGC
0
0
CTSL fwd 5 TTTGAGCCAGACTGTAGCAG3
50
30
rev ATCTTTACGTAGCCACCCATG
0
0
CTSO fwd 5 GTGGAGAAGCAAATCATGCAG3
50
30
rev GCAATACCACAAACATTACTTCCC
0
0
CTSS fwd 5 TGTGGTTGGCTATGGTGATC3
50
30
rev TTTCTGGGTAAGAGGGAAAGC
0
0
CTSV fwd 5 TGGATCATGGTGTTCTGGTG3
50
30
rev CAGTGGTTGTTCTTGTCTTTGG
0
0
CTSW fwd 5 AGTACCTTTCAGCTGTGACTG3
0
0
rev 5 CGTCCACAAAATCCCAGAAAC3
0
0
CTSZ fwd 5 TGGATGGTGTCAACTATGCC3
0
0
rev 5 GCTCCCTTCCTCTTGATGTTG3
0
0
ACTB fwd 5 CCCAGCACAATGAAGATCAAG3
0
0
rev 5 GACTCGTCATACTCCTGCTTG3
0
0
TFEB fwd 5 CTGACCCAGAAGCGAGAG3
0
0
rev 5 TCAGCATTCCCAACTCCTTG3
0
0
TFE3 fwd 5 CCTGCAGCTCCGAATTCAG3
0
0
rev 5 CTGTCAGAAGCCGAAGTCG3

Enzyme expression in Expi293 cells and enzyme
uptake assays
Expi293 cells in suspension were cotransfected with the
cDNAs of cathepsins B, C, D, L, and Z, along with the
GNPTAB S1-S3 mutant construct, as described [13].
Media was collected aseptically 2–3 days post-transfection
for use in uptake assays. For cell uptake experiments,
GNPTAB/ HeLa cells were plated on a 12-well plate
at ~ 80% confluence 1 day prior to the uptake experiment. The total protein concentration of the media containing the various secreted cathepsins was measured
using the Bradford Assay (Bio-Rad) and determined to
be roughly equivalent. Fifty microlitre aliquots of this
media containing each enzyme from the producing cells
were then added to the GNPTAB/ HeLa cells in a
final volume of 500 lL. The cells were incubated with
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the media for 24 h before being collected and processed
for immunoblotting.

Immunoblotting
Proteins resolved by using SDS/PAGE under reducing conditions were transferred to nitrocellulose membrane and
detected with antibodies as described in the figure legends.
Equal amounts of whole-cell extract were loaded on the
gels. For experiments with E-64 and pepstatin A, parental
HeLa or GNPTAB/ HeLa cells were transfected with the
human GNPTAB-V5/His cDNA in pcDNA6 using Lipofectamine 3000 (Thermo Fisher Scientific) according to the
manufacturer’s protocol. Cells were treated with the indicated concentrations of the protease inhibitors for 24 h.
Control cells were treated with only vehicle DMSO.

Results
CTSD gene expression is highly elevated in
GNPTAB / HeLa cells with partial retention of
the synthesized cathepsin D
The GNPTAB/ HeLa cell line lacks the a/b subunits
GlcNAc-1-phosphotransferase, the enzyme that generates the M-6-P moiety on lysosomal enzymes [3]. Consequently, the bulk of the acid hydrolases synthesized
by these cells are secreted rather than sorted to lysosomes [12]. Thus, it was surprising when our laboratory determined that the cathepsin D content of these
cells was actually higher than either WT parental or
GNPTG/ HeLa cells [8] (Fig. 1A). The GNPTG gene
encodes the c subunit of GlcNAc-1-phosphotransferase, which enhances the phosphorylation of a subset
of acid hydrolases, but is dispensable for the catalytic
activity of the enzyme [12,14].
In a recent study using pulse-chase experiments, we
found that 93% of the newly synthesized cathepsin D
of WT HeLa cells remained intracellular within a 5-h
time period. This is in stark contrast to the
GNPTAB/ HeLa cells where only 22.5% of the
newly synthesized cathepsin D remained intracellular,
with 77.5% being secreted into the cell culture medium
within the same time period [8]. Still, the amount of
the partially retained cathepsin D within the latter cells
exceeded the level seen in the WT cells, indicating that
in the absence of the M-6-P pathway, HeLa cells either
upregulate expression of cathepsin D and/or decrease
the turnover rate of the protein within lysosomes.
Moreover, only pro-cathepsin D was detected in the
immunoblot of whole-cell lysates from GNPTAB/
cells, whereas the fully processed heavy chain, in addition to the proform, was seen with both WT and
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Fig. 1. Analysis of cathepsin D in WT, GNPTAB/, and GNPTG/ HeLa cells. (A) Immunoblot of endogenous cathepsin D expression in
whole-cell lysates of the indicated cell lines, as determined by probing with an anti-cathepsin D antibody. (B) Confocal immunofluorescence
images of WT, GNPTAB/, and GNPTG/ HeLa cells, stained for cathepsin D and colocalized with the late endosomal/lysosomal marker
LAMP1. Scale bars correspond to 5 lM. (C) Total RNA was isolated from the three cell lines, and cathepsin D mRNA levels were measured
by RT-qPCR using the ACTB gene (encoding b-actin) as the reference gene for normalization, as described under Materials and Methods.
Error bars represent the mean  SEM of three individual determinations for the various cell lines. P = 0.00007 (Student’s t-test) for change
in CTSD expression in GNPTAB/ cells relative parental HeLa.

GNPTG/ HeLa cells [8] (Fig. 1A). A similar observation has been reported by Boonen et al. [9] and
Miller et al. [10] with our GNPTAB/ cells. Despite
the absence of GlcNAc-1-phosphotransferase, confocal
immunofluorescence microscopy showed that the procathepsin D in the GNPTAB/ cells colocalized with
the lysosomal membrane protein, LAMP1, in enlarged
late endosomes/lysosomes, indicating transport of the
aspartyl protease to this organelle (Fig. 1B). The morphology of the late endosomes/lysosomes of the
GNPTG/ cells was intermediate between WT and
GNPTAB/ cells, as previously reported [12].
Reverse transcriptase quantitative PCR (RT-qPCR)
was next performed to assess the level of cathepsin D
mRNA in the three cell lines. Using total RNA isolated from the individual cell lines, RT-qPCR analysis
determined that the cathepsin D mRNA level was
markedly elevated (between fivefold to sixfold) in the
GNPTAB/ cells compared with the WT and
GNPTG/ cells (Fig. 1C).
Elevation of cathepsin D and cathepsin L gene
expression in GNPTAB/ HeLa cells occurs
independent of TFEB and TFE3
Since the mRNA level of cathepsin D was markedly
elevated when the GNPTAB gene was inactivated in
HeLa cells, we next asked if expression of other
cathepsins at the mRNA level was also altered in the
GNPTAB/ cells. Of the 11 cathepsins tested, RTqPCR analysis showed that only five had detectable
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mRNA levels in WT HeLa cells (CTSB, CTSC, CTSF,
CTSL, and CTSZ), and of these, only the mRNA of
CTSL was also increased in the GNPTAB/ cells, relative to either WT or GNPTG/ cells (Fig. 2A). The
slightly higher mRNA levels of CTSB, CTSC, and
CTSZ under these conditions were not statistically significant.
Cathepsin D gene expression has been shown to be
regulated by TFEB, a member of the MiT/TFE family,
which binds to a common E-box response element termed CLEAR (Coordinated Lysosomal Expression and
Regulation), found in the promoter region of many
lysosomal genes [15]. In addition, TFE3, a closely
related paralog of TFEB, was also shown to upregulate expression of cathepsin D, and it was proposed
that TFE3 controls lysosomal biogenesis by regulating
an overlapping gene network [16]. We, therefore, asked
if either TFEB or TFE3, or both could be responsible
for the highly increased gene expression of CTSD
observed in GNPTAB/ HeLa cells. Total RNA isolated from these cells was subject to RT-qPCR to
assess the mRNA levels of cathepsins D, L, and Z
under basal, TFEB/TFE3 overexpression, or TFEB/
TFE3 siRNA conditions. Under basal conditions,
CTSL gene expression was increased twofold in
GNPTAB/ HeLa cells relative to WT parental HeLa
cells, which is set at 1 (Fig. 2A and 2B, CTSL). The
mRNA level of the CTSL gene was increased a further
threefold upon overexpression of TFEB and TFE3 in
GNPTAB/ cells, either individually or in combination, relative to the untransfected GNPTAB/ cells
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Fig. 2. Analysis of the expression of CTS genes in WT, GNPTAB/, and GNPTG/ HeLa cells. (A) Total RNA was isolated from the three
cell lines, and the mRNA levels of the indicated cathepsins were measured by RT-qPCR using the ACTB gene as the reference gene for
normalization. Delta Ct was calculated using the ACTB qPCR Ct value minus the qPCR Ct values of the various cathepsins. Error bars
represent the mean  SEM of three individual determinations for the various cell lines. The following P values (Student’s t-test) were
obtained for the change in gene expression between GNPTAB/ cells and parental HeLa; CTSB P = 0.11286, CTSC P = 0.21899, CTSL
P = 0.02059, and CTSZ P = 0.18135. (B) Total RNA was isolated from either untransfected GNPTAB/ cells (red), or cells transfected with
plasmids expressing TFEB and TFE3, individually or in combination, or cells transfected with oligonucleotides to silence TFEB and TFE3,
individually or in combination. The level of the indicated cathepsins under the various conditions was then measured by RT-qPCR using the
ACTB gene as the reference gene for normalization. (C) The same cells used in (B) were also analyzed for the message levels of either
TFEB or TFE3 using the ACTB gene as the reference gene for normalization. Error bars represent the mean  SEM of three individual
determinations for the different conditions (B and C).

(Fig. 2B, CTSL). In contrast to CTSL (twofold
increase in gene expression under basal conditions),
CTSD gene expression was elevated fivefold to sixfold
in GNPTAB/ cells relative to WT cells (Figs 1C and
2B, CTSD). However, any further increase in CTSD
mRNA expression when TFEB was overexpressed was
only marginal (Fig. 2B, CTSD). The overexpression of
TFE3, in this case, did not elicit an increase, as was
the case when TFEB and TFE3 were coexpressed
together. It should be noted that the mRNA level of
TFEB is not significantly different between the parental WT and GNPTAB/ HeLa cells (Fig. 2C, TFEB),
while the mRNA level of TFE3 is ~ 30% lower in
GNPTAB/ HeLa cells relative to WT cells, which is
set at 1 (Fig. 2C, TFE3).

We next performed RNA interference (RNA-i) of
TFEB and TFE3. Knocking down TFEB or TFE3,
either alone or in combination, did not significantly
decrease CTSD or CTSL gene expression in
GNPTAB/ HeLa cells (Fig. 2B, CTSL and CTSD).
The expression of CTSZ remained unchanged under
any circumstances in these experiments (Fig. 2B,
CTSZ). This result was somewhat surprising, especially when TFEB and TFE3 were overexpressed,
since the promoter region of the CTSZ gene has been
shown to contain a CLEAR element [15]. However,
it is worth noting that the CTSZ gene was not identified among the list of lysosomal hydrolase genes that
represent the most likely direct targets of TFEB in
HeLa cells [17].
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The specific effects of either overexpression or
RNA-i of TFEB and TFE3, on their respective mRNA
levels, were confirmed by the RT-qPCR data shown in
Fig. 2C. Taken together, these data indicate that the
markedly increased expression of the CTSD gene in
GNPTAB/ cells is likely occurring through a mechanism that is independent of TFEB and TFE3.
The retained cathepsin D in GNPTAB/ cells
does not undergo maturation to the two-chain
species
While the level of the retained cathepsin D in the
GNPTAB/ cells exceeded that of the WT cells, there
was a complete absence of the 30 kDa form, indicating
that the proform of the protease was not being converted to the mature two-chain form of the enzyme.
Transfection of these cells with the a/b cDNA construct, which restores phosphorylation to endogenous
acid hydrolases for transport to the lysosome [12],
gave rise to the 48 kDa intermediate and 30 kDa
mature heavy chain of cathepsin D (Fig. 3A, compare
lanes 1 and 2). The WT parental HeLa cells in this
experiment mainly contained the mature/heavy chain
form of cathepsin D (Fig. 3A, lane 7). The lack of
quantitative conversion of the pro-cathepsin D to the
mature 2-chain form is most likely due to the low
transfection efficiency of HeLa cells. Treatment of the
transfected GNPTAB/ cells with the selective cysteine protease inhibitor E-64 completely abrogated

L. Liu and B. Doray

cathepsin D processing at a concentration of 100 lM
(Fig. 3A, lane 5). This concentration of E-64 also
mostly, but not completely, inhibited the formation of
mature cathepsin D in the WT cells whereas 10 µM
was without effect (Fig. 3A, compare lanes 9 and 10),
in agreement with the previously published study using
E-64 to inhibit processing of cathepsin D [18]. This
finding confirms the reports of others implicating cysteine proteases in the processing of cathepsin D
[18,19].
The finding that E-64 prevented maturation of procathepsin D in the WT HeLa cells prompted us to ask
whether the two cysteine proteases previously shown
to mediate cathepsin D processing, namely cathepsin B
and cathepsin L, are also present in GNPTAB/
HeLa cells [18,19]. Immunoblot analysis of whole-cell
lysates showed no detectable cathepsin B in the
GNPTAB/ cells whereas the WT and GNPTG/
cells had readily detectable levels of this enzyme
(Fig. 3B). It should be noted that while the parental
HeLa cells show both the active 2-chain form of
cathepsin B (around 25 kDa) and the active singlechain form (around 30 kDa) [20], only the latter form
is detected in the GNPTG/ cells. The reason for this
discrepancy is not clear. The fact that GNPTAB/
cells have the same level of CTSB mRNA as WT cells
(Fig. 2A), but no detectable cathepsin B protein, suggests that all of the synthesized enzyme is likely being
secreted in the absence of the M-6-P pathway. On the
other hand, only pro-cathepsin L was detected in all 3

Fig. 3. Effect of the cysteine protease inhibitor E-64 on cathepsin D processing. (A) GNPTAB/ cells transfected with the human GNPTABV5/His cDNA construct, and untransfected WT parental HeLa cells were treated with the indicated concentrations of E-64 for 24 h.
Equivalent amount of whole-cell lysates were loaded for immunoblotting and probed for endogenous cathepsin D. * Indicates a longer
exposure of the cathepsin D blot. (B) Immunoblot of endogenous cathepsin B and cathepsin L in whole-cell lysates of the indicated cell
lines, as determined by probing with their respective antibodies. * Indicates a longer exposure of the whole cathepsin L blot.
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cell lines with the anti-cathepsin L antibody used in
this study, even with the long exposure (Fig. 3B*).
Cell uptake of cathepsin B facilitates processing
of cathepsin D
We next asked whether delivery of exogenous cathepsin B to the lysosomes of the GNPTAB/ cells could
partially restore processing of the endogenous procathepsin D. To this end, cathepsins B, C, L, and Z
were coexpressed with a truncated form of GlcNAc-1phosphotransferase (S1-S3) that exhibits high activity
toward lysosomal enzymes in Expi293 cells [13]. These
four cathepsins were selected on the basis of their
expression in HeLa cells (Fig. 2A). We have previously
shown that coexpression of a number of lysosomal
enzymes with S1-S3 in Expi293 cells resulted in the
secretion of highly phosphorylated enzymes into the
media [13]. Since the uptake of the secreted enzymes
via the cell-surface cation-independent M-6-P receptor
is dependent upon the extent of phosphorylation, we
surmised that coexpression with S1-S3 would result in
the production of enzymes with a higher M-6-P content for use in the uptake experiments.
The media collected from these cultures contained
high levels of each protease (Fig. 4A, arrows). The
conditioned media were then added to cultures of
GNPTAB/ cells for 24 h. Immunoblot analysis of
whole-cell lysates probed for cathepsin D showed that
only cathepsin B-containing conditioned media facilitated processing of pro-cathepsin D to the mature species (Fig. 4B, lane 4). Differential processing of the
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cathepsin D N-linked glycans due to the lack of phosphorylation of the high mannose-type sugar chains
results in the slower migration of the cathepsin D
heavy chain in GNPTAB/ cells compared with WT
HeLa cells (Fig. 4B, compare lanes 1 and 4) [21, 22].
The cathepsin B that was fed to the cells (Fig. 4C,
lane 4) and taken up from the conditioned media was
also processed to a mature species that migrated somewhat slower than the endogenous, mature cathepsin B
in WT Hela cells (Fig. 4C, compare lanes 1 and 3).
The basis for the discrepancy is not clear at this time.

Discussion
Numerous studies published over the last several decades have implicated cathepsin D in a variety of physiological processes as well as diseased states [23].
Hence, a clear understanding of the gene regulatory
networks underlying control of CTSD gene expression,
as well as the mechanisms involved in the proteolytic
processing of cathepsin D under normal and pathological conditions, is important. Here, we present evidence
for the sustained elevation of CTSD gene expression
at the transcriptional level when the M-6-P pathway is
abrogated in HeLa cells. This lysosomal stress results
in an approximately sixfold increase in the steady-state
message level of the CTSD gene that is still maintained
when the transcription factors TFEB and TFE3 are
simultaneously silenced by RNA-i. In addition, GFPtagged TFEB or TFE3 did not show any discernible
difference in subcellular localization between the WT
parental and GNPTAB/ HeLa cells (data not

Fig. 4. Cell uptake of exogenously added cathepsins. (A) Enzyme produced by Expi293 cells was collected from the media of cells
transfected with the cDNAs of the respective cathepsins and cotransfected with the a/b precursor or the S1-S3 mutant. Ten microlitre
media were resolved by SDS/PAGE and the gel stained with Coomassie Brilliant Blue-250. The position of the secreted cathepsins are
indicated by black arrows. (B) Immunoblot of GNPTAB/ cells following uptake of enzyme from the media, and probed for endogenous
cathepsin D. (C) Immunoblot analysis of parental HeLa cells (lane 1), and untreated GNPTAB/ cells (lane 2), or treated with media
containing secreted cathepsin B (lane 3), and probed for cathepsin B. Ten microlitre of the Expi293 cell media containing the secreted
cathepsin B was loaded in lane 4.
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shown), in contrast to the enhanced nuclear translocation of TFEB that has been observed with renal
glomerular cells isolated from Gnptab/ mice [24].
Taken together, these results suggest that an alternate
mechanism/s must be present in HeLa cells that contribute to the upregulation of gene expression due to
inactivation of the a/b subunits of GlcNAc-1-phosphotransferase. The GNPTAB/ HeLa cells have been
subject to long-term adaptation to lysosomal stress
due to many passages of the cell line over time. The
roles of TFEB and TFE3 in lysosomal regulation for
cellular adaptation under a variety of acute stress conditions such as nutrient deprivation and pathogen
infection are well documented [11]. However, this does
not rule out the existence of additional pathways that
may be involved in lysosomal homeostasis, especially
when lysosome function is impaired in the long run.
Previously, we showed that the cathepsin D synthesized by GNPTAB/ cells is not phosphorylated and
is hyper-secreted [12]. In view of the substantial
increase in cathepsin D expression at both the mRNA
and protein levels in these cells, it is possible that a
fraction of the newly synthesized cathepsin D is nonspecifically incorporated into clathrin-coated vesicles
that bud off the TGN and are trafficked to the endosome/lysosome compartment. In addition, some of the
cathepsin D may be targeted to the lysosome by a M6-P-independent mechanism [9,25,26]. Our finding that
GNPTAB/ cells are unable to process this retained
pro-cathepsin D to the mature heavy and light chains
provided a useful system for searching for a protease
that acts on this intermediate. The first clue that implicated cathepsin B came from immunoblot analysis of
whole-cell lysates which showed good expression of
the cysteine protease cathepsin L, but no detectable
cathepsin B, in the mutant cells. Since the mutant cells
had similar levels of CTSB mRNA as WT cells, the
lack of cathepsin B is presumably due to hypersecretion of the enzyme. Evidence for the role of cathepsin
B in this process was then obtained by the cellular
uptake experiment wherein conditioned media containing each of the five expressed cathepsins, which we
show are synthesized by the GNPTAB/ cells
(Fig. 2A), were individually fed to this cell type. Our
results show that only cathepsin B was capable of
cleaving the endogenous pro-cathepsin D. Consistent
with a role for cathepsin B in this processing is the
finding that the cysteine protease inhibitor, E-64,
blocked pro-cathepsin D conversion in the WT HeLa
cells, as well as in the GNPTAB/ cells transfected
with a cDNA construct encoding the a/b subunits of
GlcNAc-1-phosphotransferase. Cathepsin L, in addition to cathepsin B, has been reported to be involved
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in pro-cathepsin D maturation [18]. While our cell
uptake data favor cathepsin B acting alone in this process, at least in HeLa cells, we cannot exclude a role
for cathepsin L since our anti-cathepsin L antibody
detected only the proform of cathepsin L in both parental and GNPTAB/ HeLa cells, and not the mature
active form.
In conclusion, we present our data that inactivation
of the M-6-P pathway in HeLa cells results in an
upregulation of CTSD gene expression at the transcriptional level that occurs independent of TFEB and
TFE3. In addition, we determine that it is the lack of
cathepsin B in these GNPTAB/ cells that is responsible for the failure of the retained cathepsin D to
undergo proteolytic processing and maturation.
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